European Journal of Cardiovascular Medicine

Introduction: The Covid 19 pandemic has moved the world with devastating outcomes in the first wave (2019-20) and the second wave (2020-21). Additionally, in the second wave descending phase, mucormycosis, which is almost the rarest disease, has come rampant, again creating panic for the human race. Materials and Methods: 200 consecutive Mucormycosis cases were admitted, managed both medically and surgical by a multidisciplinary team approach over a period of 6 months. Results: Data is analyzed statistically in a Microsoft Excel sheet, represented pictorially by bar diagrams. Conclusion: Post Covid Mucormycosis differs from the mucormycosis seen in immunodeficient patients by pathophysiology, and the management protocols also differ. It has high mortality and morbidity with repeated complex surgical procedures. It requires a team approach and prolonged, repeated reconstructive, and rehabilitative procedures.